PubMed Health⌕ Search

Biomedical subjects

M A Macías

Publications and source records attributed to M A Macías.

5 recordsLinked to original sources

Adhesion molecules as a prognostic marker of liver cirrhosis.

OBJECTIVE: Endothelial activation plays an active role in modifications of the circulatory status of cirrhotic patients. Soluble endothelial adhesion molecules, induced by pro-inflammatory cytokines, could be considered markers of endothelial activation. Their role in the natural history of cirrhosis and portal hypertension has not been reported. Our objective was to analyze the prognostic value of soluble adhesion molecules in cirrhotic patients. MATERIAL AND METHODS: Serum concentrations of soluble CD14, soluble receptors of tumor necrosis factor alpha and adhesion molecules ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule 1) as well as mean blood pressure, plasma renin activity, aldosterone, vasopressin and norepinephrine concentrations were determined in 64 cirrhotic patients (Child-Pugh class: A 48.4%, B 34.4%, C 17.2%), without any evidence of infection, and in 25 healthy controls. Patients were followed-up for a mean of 36.4 (range 6-60) months. RESULTS: Increased concentrations of soluble CD14, tumor necrosis factor receptors and ICAM-1 and VCAM-1 were detected in cirrhotic patients when compared with healthy controls. Tumor necrosis factor receptors and adhesion molecule concentrations were both significantly higher in advanced phases of cirrhosis (Child Pugh class C and B versus A). Fifteen patients died as a related consequence of liver cirrhosis. Multivariate analysis demonstrated that Child-Pugh score and serum levels of tumor necrosis factor receptor I and ICAM-1 were associated with mortality. CONCLUSIONS: In addition to the classic factor implicated in mortality (Child-Pugh class), alterations in inflammation-related components and soluble adhesion molecules, as representatives of hemodynamic alterations, are of prognostic significance in cirrhotic patients.

Aged↗

[Usefulness of ultrasonography in the early diagnosis of hepatocarcinoma in patients with liver cirrhosis].

OBJECTIVE: To assess the efficacy of a screening program of ultrasonography (U.S.) every six months in the early diagnosis of HCC in liver cirrhosis patients. PATIENTS AND METHODS: We review retrospectively the 99 HCC detected by U.S. in our service from January 1991 to July 1994. We compared patients in the ultrasonography screening program (Group I) with patients who did not (Group II) and, also with, patients with a previous diagnosis of cirrhosis (Group IIa) and patients with simultaneous HCC diagnosis of and cirrhosis (Group IIb). Liver function, the tumor size and extension, and the chance of treatment at the time of diagnosis were analyzed in each group. RESULTS: Twenty (58%) HCC out of 34 from group I single nodules < 5 cm in diameter vs seven (11%) out of 65 from group II (p < 0.001) were detected and this difference persisted between group I and groups IIa and IIb (p = 0.002 and p < 0.001). Most patients with grade C Child-Pugh's score (24 from 27) in each group showed a > 5 cm or multinodular HCC. Ten patients from group I were treated vs 4 from group II (p = 0.001). CONCLUSIONS: Ultrasonography screening program is useful in the early diagnosis of HCC in liver cirrhosis patients and increases the chances of treatment.

Carcinoma, Hepatocellular↗

[ADAM syndrome].

We present six cases of ADAM syndrome, that we have been studying at the Unit of Clinical Genetics of the Hospital Infantil de México. We wish to stress how it is possible using medical photography to appreciate the different characteristics of ADAM syndrome: A-Amniotic, D-Deformation, A-Adhesions, M-Mutilation.

Abnormalities, Multiple↗